Skip to main content
. 2021 Jan 1;278(7):2327–2336. doi: 10.1007/s00405-020-06503-9

Table 3.

Demographic and clinical characteristics of patients with and without smell/taste dysfunction in Group P

With STD in Group P (n:32) Without STD in Group P (n:21) p
Demographic features
 Age [mean (± SD)] 41.18(± 14.29) 45.14(± 13.85) 0.323a
 F/M (n) 16/16 13/8 0.569e
Comorbidities [n (%)]
 Hypertension 6 (18.8) 2 (9.5) 0.455c
 Diabetes mellitus 3 (9.4) 2 (9.5) 1.00c
 Chronic respiratory disease 3 (9.4) 1 (4.8) 1.00c
 Neurologic disease 1 (3.1) 1 (4.8) 1.00c
 Smoking 10 (31.3) 10 (47.6) 0.361e
 Sinusitis/allergic rhinitis 10 (31.3) 4 (19) 0.505e
 Head trauma 3 (9.4) 2 (9.5) 1.00c
Complaints when the sample received from the patient [n (%)]
 Fever 20 (62.5) 9 (42.9) 0.261e
 Cough 20 (62.5) 8 (38.1) 0.144e
 Sore throat 4 (12.5) 3 (14.3) 1.00c
 Shortness of breath 9 (28.1) 6 (28.6) 1.00e
 Headache 12 (37.5) 4 (19.0) 0.260e
 Myalgia 21 (65.6) 6 (28.6) 0.018e
 Malaise 12 (37.5) 8 (38.1) 1.00e
 Nasal obstruction 5 (15.6) 1 (4.8) 0.384c
 Rhinorrhea 1 (3.1) 0 (0) 1.00c
 GIS symptoms 10 (31.3) 7 (33.3) 1.00e
Radiologic and labaratory findings
 Ground-glass apperance on CT [n (%)] 21 (65.6) 6 (28.6) 0.018e
 CRP [median (min–max)] 8.07 (1.0–349.0) 3.14 (0.10–435.24) 0.355d
 L [mean (± SD)] 1.43 (± 0.85) 2.10 (± 1.08) 0.016a
 N/L [median (min–max)] 2.24 (0.71–12.5) 2.71 (1.30–29.40) 0.940d

Bold prints in ‘p’ column indicate a significant difference between with STD patients and without STD patients

% percentage, CRP C-reactive protein, COVID-19 coronavirus Didease 2019, CT computed tomography, F female, GIS gastrointestinal system, Group P COVID-19 positive patients, L lymphocyte count, M male, max maximum, min minimum, N/L neutrophil/lymphoctye ratio, SD standard deviation, STD smell/taste dysfunction

aindependent samples t test

bPearson chi square

cFisher exact test

dMann–Whitney U test

econtinuity correction